Perrigo (PRGO) Revenue (2012 - 2026)
Perrigo (PRGO) reported Revenue of $969.2 million for Q1 2026, down 7.16% year-over-year from $1.0 billion in Q1 2025, and down 12.65% quarter-over-quarter from $1.1 billion in Q4 2025.
Perrigo (PRGO) Revenue (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Revenue data on file, last reported at $969.2 million in Q1 2026.
- Revenue for Q1 2026 came in at $969.2 million, down 7.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 billion (down 3.62% YoY), and the FY2025 annual result was $4.3 billion, down 2.75% from the prior year.
- Revenue declined to $969.2 million in Q1 2026 per PRGO's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Revenue peaked at $1.2 billion in Q3 2023 and troughed at $969.2 million in Q1 2026.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2024: Revenue rose 14.33% in 2022, then retreated 10.69% in 2024.
- A 5-year view of Revenue shows it stood at $1.2 billion in 2022, then advanced by 0.14% to $1.2 billion in 2023, then decreased by 1.61% to $1.1 billion in 2024, then retreated by 2.52% to $1.1 billion in 2025, then slipped by 12.65% to $969.2 million in 2026.
- Business Quant data shows PRGO's Revenue at $969.2 million in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | 969.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 969.20 Mn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 27, 2025 | 1.04 Bn |
| Jun 28, 2025 | 1.06 Bn |
| Mar 29, 2025 | 1.04 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Sep 28, 2024 | 1.09 Bn |
| Jun 29, 2024 | 1.07 Bn |
| Mar 30, 2024 | 1.08 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.12 Bn |
| Jul 1, 2023 | 1.19 Bn |
| Apr 1, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.16 Bn |
| Oct 1, 2022 | 1.10 Bn |
| Jul 2, 2022 | 1.12 Bn |
| Apr 2, 2022 | 1.07 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Oct 2, 2021 | 1.04 Bn |
| Jul 3, 2021 | 981.10 Mn |